References
- Ahn EJ, Lee RA, Chung SS, Kim KH, Park EB. The colorectal cancer risk of meat intake, smoking, and CYP2E1 polymorphisms: The comparison of colorectal cancer patients with controls. J Korean Surg Soc. 2006. 71: 262-268.
- Cai L, Zheng ZL, Zhang ZF. Cytochrome P450 2E1 polymorphism and the risk of gastric cancer. Toxicol. 1998. 152: 276-281.
- Das J, Ghosh J, Manna P, Parames CS. Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicol. 2010. 269: 24-34. https://doi.org/10.1016/j.tox.2010.01.003
- Fritsche E, Pettman GS, Bell DA. Localization, sequence analysis and ethnic distribution of a 96 bp insertion in the promoter of the human CYP2E1 gene. Mutat Res Genomics. 2000. 432: 1-5. https://doi.org/10.1016/S1383-5726(99)00009-6
- Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P450 2E1 in the oxidation of many low molecular weight cancer suspects.Chem Res Toxicol. 1991. 4: 168-179. https://doi.org/10.1021/tx00020a008
- Hayashi SI, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450 2E1 gene. J Biochem. 1991. 110: 559-565. https://doi.org/10.1093/oxfordjournals.jbchem.a123619
- Kato S, Shieds PG, Caporaso NE. Cytochrome P450 2E1 genetic polymorphism, racial variation, and lung cancer risk. Cancer Res. 1992. 52: 6712-6715.
- Kim RB, O'Shea D, Wilkinson GR. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther. 1995. 57: 645-655. https://doi.org/10.1016/0009-9236(95)90227-9
- Nam HM, Park JW, Song YJ, Yun HY, Park JS, Hyun TS. Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol. 2005. 11: 3175-3181. https://doi.org/10.3748/wjg.v11.i21.3175
- McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol. 1998. 152: 276-281. https://doi.org/10.1006/taap.1998.8532
- Ohkubo Y, Ueta A, Ando N, Ito T, Yamaguchi S, Mizuno K. Novel mutations in the cytochrome P450 2C19 gene: a pitfall of the PCR-RFLP method for identifying a common mutation. J Hum Genet. 2006. 51: 118-123. https://doi.org/10.1007/s10038-005-0332-y
- Paik SW, Yoon JH, Hwang YJ, Jang YH, Lee HS, Kim CY. Genetic Polymorphism of Cytochrome P450 2E1 in Hepatocellular Carcinoma Patients in Korea. Korean J Gastroenterol. 30: 503-512.
- Park JS, Kim H, Song YJ, Yun HY, Kang JW, Kim YD, Nan HM. Effects of environmental carcinogens and genetic polymorphisms of CYP2E1 and NAT2 on gastric carcinogenesis. J Korean Surg Soc. 2000. 59: 488-499.
- Seitz HK, Simanowsky UA. Alcohol and carcinogenesis. Ann Rev Nutr. 1988. 8: 99-119. https://doi.org/10.1146/annurev.nu.08.070188.000531
- Tsutsumi M, Matsuda Y, Takada A. Role of ethanol inducible cytochrome P450 2E1 in the development of hepatocellular carcinoma by the chemical carcinogen, N-nitrosodimethylamine. Hepatology. 1993. 18: 1483-1489. https://doi.org/10.1002/hep.1840180630
- Uematsu F, Kikuchi H, Motomiya M. Association between restriction fragment length polymorphism of the human cytochrome P450 2E1 in a Swedish population: relationship to incidence of lung cancer. Febs Lett. 1993. 319: 207-211. https://doi.org/10.1016/0014-5793(93)80547-8